KRAS and colorectal carcinoma: Chen et al. reported that in CRC, KRAS mutations were often associated with lymph node involvement and poor prognosis, with a significant decrease in overall survival (OS), in particular those with a KRAS codon 13 mutation, compared with the KRAS wild-type [28].